Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers.

Peng M, Bakker JL, Dicioccio RA, Gille JJ, Zhao H, Odunsi K, Sucheston L, Jaafar L, Mivechi NF, Waisfisz Q, Ko L.

Genes Cancer. 2013 Jan;4(1-2):15-25. doi: 10.1177/1947601913486344.

2.

Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.

Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM; Australian Cancer Study (Ovarian Cancer) Study Group, Köbel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G; Australian Ovarian Cancer Study Group, Cramer DW, Cunningham JM, Dicioccio RA, Doherty JA, Easton DF, Fredericksen ZS, Fridley BL, Gates MA, Gayther SA, Gentry-Maharaj A, Høgdall E, Kjaer SK, Lurie G, Menon U, Moorman PG, Moysich K, Ness RB, Palmieri RT, Pearce CL, Pharoah PD, Ramus SJ, Song H, Stram DO, Tworoger SS, Van Den Berg D, Vierkant RA, Wang-Gohrke S, Whittemore AS, Wilkens LR, Wu AH, Schildkraut JM, Sellers TA, Goode EL; Ovarian Cancer Association Consortium.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1822-30. doi: 10.1158/1055-9965.EPI-09-1317. Epub 2010 Jun 22.

3.

Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.

Lurie G, Wilkens LR, Thompson PJ, Carney ME, Palmieri RT, Pharoah PD, Song H, Hogdall E, Kjaer SK, DiCioccio RA, McGuire V, Whittemore AS, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Goodman MT; Ovarian Cancer Association Consortium.

Int J Cancer. 2011 Feb 15;128(4):936-43. doi: 10.1002/ijc.25403.

4.

Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.

Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, Wang-Gohrke S, Hein R, Green AC, Lissowska J, Carney ME, Lurie G, Wilkens LR, Ness RB, Pearce CL, Wu AH, Van Den Berg DJ, Stram DO, Terry KL, Whiteman DC, Whittemore AS, DiCioccio RA, McGuire V, Doherty JA, Rossing MA, Anton-Culver H, Ziogas A, Hogdall C, Hogdall E, Krüger Kjaer S, Blaakaer J, Quaye L, Ramus SJ, Jacobs I, Song H, Pharoah PD, Iversen ES, Marks JR, Pike MC, Gayther SA, Cunningham JM, Goodman MT, Schildkraut JM, Chenevix-Trench G, Berchuck A, Sellers TA; Ovarian Cancer Association Consortium, Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):600-4. doi: 10.1158/1055-9965.EPI-09-0861.

5.

Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer.

Quaye L, Tyrer J, Ramus SJ, Song H, Wozniak E, DiCioccio RA, McGuire V, Høgdall E, Høgdall C, Blaakaer J, Goode EL, Schildkraut JM, Easton DF, Krüger-Kjaer S, Whittemore AS, Gayther SA, Pharoah PD.

PLoS One. 2009 Jun 19;4(6):e5983. doi: 10.1371/journal.pone.0005983.

6.

Complex segregation analysis of pedigrees from the Gilda Radner Familial Ovarian Cancer Registry reveals evidence for mendelian dominant inheritance.

Tayo BO, DiCioccio RA, Liang Y, Trevisan M, Cooper RS, Lele S, Sucheston L, Piver SM, Odunsi K.

PLoS One. 2009 Jun 17;4(6):e5939. doi: 10.1371/journal.pone.0005939.

7.

Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study.

Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, Gentry-Maharaj A, Jacobs IJ, Webb PM, Beesley J, Chen X; Australian Cancer (Ovarian) Study; Australian Ovarian Cancer Study Group, Rossing MA, Doherty JA, Chang-Claude J, Wang-Gohrke S, Goodman MT, Lurie G, Thompson PJ, Carney ME, Ness RB, Moysich K, Goode EL, Vierkant RA, Cunningham JM, Anderson S, Schildkraut JM, Berchuck A, Iversen ES, Moorman PG, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Anton-Culver H, Ziogas A, Brewster WR, Ponder BA, Easton DF, Gayther SA, Pharoah PD; Ovarian Cancer Association Consortium (OCAC).

Hum Mol Genet. 2009 Jun 15;18(12):2297-304. doi: 10.1093/hmg/ddp138. Epub 2009 Mar 20.

8.

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.

Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, Høgdall C, Blaakaer J; Ovarian Cancer Association Consortium, Easton DF, Ponder BA, Jacobs IJ, Menon U, Whittemore AS, Krüger-Kjaer S, Pearce CL, Pharoah PD, Gayther SA.

Br J Cancer. 2009 Mar 24;100(6):993-1001. doi: 10.1038/sj.bjc.6604947. Epub 2009 Feb 24.

9.

Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium.

Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, Doherty JA, Rossing MA, Whittemore AS, McGuire V, DiCioccio RA, Goodman MT, Lurie G, Carney ME, Wilkens LR, Ness RB, Moysich KB, Edwards R, Jennison E, Kjaer SK, Hogdall E, Hogdall CK, Goode EL, Sellers TA, Vierkant RA, Cunningham JM, Schildkraut JM, Berchuck A, Moorman PG, Iversen ES, Cramer DW, Terry KL, Vitonis AF, Titus-Ernstoff L, Song H, Pharoah PD, Spurdle AB, Anton-Culver H, Ziogas A, Brewster W, Galitovskiy V, Chenevix-Trench G; Australian Cancer Study; Australian Ovarian Cancer Study Group.

Br J Cancer. 2009 Jan 27;100(2):412-20. doi: 10.1038/sj.bjc.6604820. Epub 2009 Jan 6. Erratum in: Br J Cancer. 2009 Nov 17;101(10):1805. Cunningham, J C [corrected to Cunningham, J M].

10.

Consideration of hereditary nonpolyposis colorectal cancer in BRCA mutation-negative familial ovarian cancers.

South SA, Vance H, Farrell C, DiCioccio RA, Fahey C, Piver MS, Rodabaugh KJ.

Cancer. 2009 Jan 15;115(2):324-33. doi: 10.1002/cncr.24012.

11.

Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.

Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, Chenevix-Trench G, Chang-Claude J, Cunningham JM, Dicioccio RA, Doherty JA, Easton DF, Edlund CK, Gayther SA, Gentry-Maharaj A, Goode EL, Goodman MT, Kjaer SK, Hogdall CK, Hopkins MP, Jenison EL, Blaakaer J, Lurie G, McGuire V, Menon U, Moysich KB, Ness RB, Pearce CL, Pharoah PD, Pike MC, Ramus SJ, Rossing MA, Song H, Terada KY, Vandenberg D, Vierkant RA, Wang-Gohrke S, Webb PM, Whittemore AS, Wu AH, Ziogas A, Berchuck A, Schildkraut JM; Ovarian Cancer Association Consortium; Australian Cancer Study (Ovarian Cancer Group); Australian Ovarian Cancer Study Group.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3567-72. doi: 10.1158/1055-9965.EPI-08-0548.

12.

Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer.

Song H, Koessler T, Ahmed S, Ramus SJ, Kjaer SK, Dicioccio RA, Wozniak E, Hogdall E, Whittemore AS, McGuire V, Ponder BA, Turnbull C, Hines S, Rahman N; Breast Cancer Susceptibility Collaboration UK, Eeles RA, Easton DF, Gayther SA, Dunning AM, Pharoah PD.

Cancer Res. 2008 Nov 1;68(21):8837-42. doi: 10.1158/0008-5472.CAN-08-2363.

13.

Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.

Mann A, Hogdall E, Ramus SJ, DiCioccio RA, Hogdall C, Quaye L, McGuire V, Whittemore AS, Shah M, Greenberg D, Easton DF, Ponder BA, Kjaer SK, Gayther SA, Thompson DJ, Pharoah PD, Song H.

Eur J Cancer. 2008 Oct;44(15):2259-65. doi: 10.1016/j.ejca.2008.07.010. Epub 2008 Aug 22.

14.

A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.

Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H.

Carcinogenesis. 2008 Oct;29(10):1963-6. doi: 10.1093/carcin/bgn172. Epub 2008 Jul 27.

PMID:
18660546
15.

Multiple loci with different cancer specificities within the 8q24 gene desert.

Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, Whittemore AS, Gayther SA, Giles GG, Guy M, Edwards SM, Morrison J, Donovan JL, Hamdy FC, Dearnaley DP, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Brown PM, Hopper JL, Neal DE, Pharoah PD, Ponder BA, Eeles RA, Easton DF, Dunning AM; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators.

J Natl Cancer Inst. 2008 Jul 2;100(13):962-6. doi: 10.1093/jnci/djn190. Epub 2008 Jun 24.

16.

Consortium analysis of 7 candidate SNPs for ovarian cancer.

Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, DiCioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, Pharoah PDP, Garcia-Closas M, Chanock S, Lissowska J, Brinton L, Terry KL, Cramer DW, Tworoger SS, Hankinson SE, Berchuck A, Moorman PG, Schildkraut JM, Cunningham JM, Liebow M, Kjaer SK, Hogdall E, Hogdall C, Blaakaer J, Ness RB, Moysich KB, Edwards RP, Carney ME, Lurie G, Goodman MT, Wang-Gohrke S, Kropp S, Chang-Claude J, Webb PM, Chen X, Beesley J, Chenevix-Trench G, Goode EL.

Int J Cancer. 2008 Jul 15;123(2):380-388. doi: 10.1002/ijc.23448.

17.

Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.

Song H, Hogdall E, Ramus SJ, Dicioccio RA, Hogdall C, Quaye L, McGuire V, Whittemore AS, Shah M, Greenberg D, Easton DF, Kjaer SK, Pharoah PD, Gayther SA.

Clin Cancer Res. 2008 Feb 15;14(4):1090-5. doi: 10.1158/1078-0432.CCR-07-1195.

18.

Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.

Beesley J, Jordan SJ, Spurdle AB, Song H, Ramus SJ, Kjaer SK, Hogdall E, DiCioccio RA, McGuire V, Whittemore AS, Gayther SA, Pharoah PD, Webb PM, Chenevix-Trench G; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer); Australian Breast Cancer Family Study.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2557-65.

19.

Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.

Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, Garlinghouse-Jones K, Oakley-Girvan I, Jacobs IJ, Hardy RM, Whittemore AS, Ponder BA, Piver MS, Pharoah PD, Gayther SA.

Hum Mutat. 2007 Dec;28(12):1207-15.

PMID:
17688236
20.

Screening for the BRCA1-ins6kbEx13 mutation: potential for misdiagnosis. Mutation in brief #964. Online.

Ramus SJ, Harrington PA, Pye C, Peock S, Cook MR, Cox MJ, Jacobs IJ, DiCioccio RA, Whittemore AS, Piver MS, EMBRACE, Easton DF, Ponder BA, Pharoah PD, Gayther SA.

Hum Mutat. 2007 May;28(5):525-6.

PMID:
17397054
21.

Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.

Song H, Ramus SJ, Kjaer SK, Hogdall E, Dicioccio RA, Whittemore AS, McGuire V, Hogdall C, Jacobs IJ, Easton DF, Ponder BA, Dunning AM, Gayther SA, Pharoah PD.

PLoS One. 2007 Mar 7;2(3):e268.

22.

Common variants in RB1 gene and risk of invasive ovarian cancer.

Song H, Ramus SJ, Shadforth D, Quaye L, Kjaer SK, Dicioccio RA, Dunning AM, Hogdall E, Hogdall C, Whittemore AS, McGuire V, Lesueur F, Easton DF, Jacobs IJ, Ponder BA, Gayther SA, Pharoah PD.

Cancer Res. 2006 Oct 15;66(20):10220-6.

23.

Common variants in mismatch repair genes and risk of invasive ovarian cancer.

Song H, Ramus SJ, Quaye L, DiCioccio RA, Tyrer J, Lomas E, Shadforth D, Hogdall E, Hogdall C, McGuire V, Whittemore AS, Easton DF, Ponder BA, Kjaer SK, Pharoah PD, Gayther SA.

Carcinogenesis. 2006 Nov;27(11):2235-42. Epub 2006 Jun 13.

PMID:
16774946
24.

Analysis of ovarian tumors for the presence of human papillomavirus DNA.

Quirk JT, Kupinski JM, DiCioccio RA.

J Obstet Gynaecol Res. 2006 Apr;32(2):202-5.

PMID:
16594925
25.

Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.

Lee JS, John EM, McGuire V, Felberg A, Ostrow KL, DiCioccio RA, Li FP, Miron A, West DW, Whittemore AS.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):359-63.

26.

Polymorphisms in DNA repair genes and epithelial ovarian cancer risk.

Auranen A, Song H, Waterfall C, Dicioccio RA, Kuschel B, Kjaer SK, Hogdall E, Hogdall C, Stratton J, Whittemore AS, Easton DF, Ponder BA, Novik KL, Dunning AM, Gayther S, Pharoah PD.

Int J Cancer. 2005 Nov 20;117(4):611-8.

27.

Aberrations of TACC1 and TACC3 are associated with ovarian cancer.

Lauffart B, Vaughan MM, Eddy R, Chervinsky D, DiCioccio RA, Black JD, Still IH.

BMC Womens Health. 2005 May 26;5:8.

28.

BRAF polymorphisms and the risk of ovarian cancer of low malignant potential.

Kelemen L, James M, Spurdle A, Campbell I, Chang-Claude J, Peel D, Anton-Culver H, Berchuck A, Schildkraut J, Whittemore A, McGurie V, DiCioccio RA, Duffy D, Chenevix-Trench G.

Gynecol Oncol. 2005 Jun;97(3):807-12.

29.

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.

Whittemore AS, Balise RR, Pharoah PD, Dicioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, Piver MS.

Br J Cancer. 2004 Nov 29;91(11):1911-5.

30.

STK15 polymorphisms and association with risk of invasive ovarian cancer.

Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V, Hogdall E, Shah MN, Luben RN, Easton DF, Jacobs IJ, Ponder BA, Whittemore AS, Gayther SA, Pharoah PD, Kruger-Kjaer S.

Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1589-94.

31.

The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity.

Ostrow KL, McGuire V, Whittemore AS, DiCioccio RA.

Cancer Genet Cytogenet. 2004 Sep;153(2):177-80.

PMID:
15350310
32.

Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.

Werness BA, Ramus SJ, DiCioccio RA, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Tsukada Y, Harrington P, Gayther SA, Ponder BA, Piver MS.

Int J Gynecol Pathol. 2004 Jan;23(1):29-34.

PMID:
14668547
33.

BRCA1 mutations.

DiCioccio RA, Werness BA, Piver MS.

Genes Chromosomes Cancer. 2003 Jun;37(2):222. No abstract available.

PMID:
12696073
34.

BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.

Ramus SJ, Pharoah PD, Harrington P, Pye C, Werness B, Bobrow L, Ayhan A, Wells D, Fishman A, Gore M, DiCioccio RA, Piver MS, Whittemore AS, Ponder BA, Gayther SA.

Cancer Res. 2003 Jan 15;63(2):417-23.

35.

Comparison of techniques for the successful detection of BRCA1 mutations in fixed paraffin-embedded tissue.

Bernstein JL, Thompson WD, Casey G, DiCioccio RA, Whittemore AS, Diep AT, Thakore SS, Vaziri S, Xue S, Haile RW.

Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):809-14.

36.

Transitional cell ovarian carcinoma in a BRCA1 mutation carrier.

Werness BA, DiCioccio RA.

Obstet Gynecol. 2002 Aug;100(2):385; author reply 385. No abstract available.

PMID:
12151180
37.

Detection of Mycoplasma ribosomal DNA sequences in ovarian tumors by nested PCR.

Quirk JT, Kupinski JM, DiCioccio RA.

Gynecol Oncol. 2001 Dec;83(3):560-2.

PMID:
11733972
38.

A BRCA1 variant, IVS23+1G-->A, causes abnormal RNA splicing by deleting exon 23.

Laskie Ostrow K, DiCioccio RA, McGuire V, Whittemore AS.

Cancer Genet Cytogenet. 2001 Jun;127(2):188-90. No abstract available.

PMID:
11428389
39.

Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.

Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Dicioccio RA, Tsukada Y, Ponder BA, Piver MS.

Hum Pathol. 2000 Nov;31(11):1420-4.

PMID:
11112219
40.

Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation.

Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Tsukada Y, Ponder BA, Piver MS.

Int J Gynecol Pathol. 2000 Oct;19(4):390-4.

PMID:
11109172
41.

Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry.

Piver MS, Tsukada Y, Werness BA, DiCioccio RA, Whittemore AS, Ponder BA.

Gynecol Oncol. 2000 Aug;78(2):166-70.

PMID:
10926797
42.

Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.

Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder BA, Piver MS.

J Natl Cancer Inst. 2000 Jul 5;92(13):1088-91.

PMID:
10880552
43.

Literature on BRCA1 mutations not cited.

DiCioccio RA.

Am J Pathol. 2000 Apr;156(4):1478. No abstract available.

44.

Microsatellite instability in ovarian and other pelvic carcinomas.

Allen HJ, DiCioccio RA, Hohmann P, Piver MS, Tworek H.

Cancer Genet Cytogenet. 2000 Mar;117(2):163-6.

PMID:
10704691
45.

Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors.

Tworek H, Peng R, Fetzer S, Werness BA, Piver MS, Allen HJ, DiCioccio RA.

Cancer Genet Cytogenet. 1999 Jul 15;112(2):105-18.

PMID:
10686936
46.

Classification of IVS1-10T-->C as a polymorphism of BRCA1.

Fetzer S, Tworek HA, Piver MS, DiCioccio RA.

Cancer Genet Cytogenet. 1999 Aug;113(1):58-64.

PMID:
10459348
47.

Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation.

Wong C, DiCioccio RA, Allen HJ, Werness BA, Piver MS.

Cancer Genet Cytogenet. 1998 Nov;107(1):21-7.

PMID:
9809029
48.

Correlation of TP53 mutations and p53 expression in ovarian tumors.

DiCioccio RA, Werness BA, Peng R, Allen HJ, Piver MS.

Cancer Genet Cytogenet. 1998 Sep;105(2):93-102.

PMID:
9723023
49.

An alternative splice site junction in exon 1a of the BRCA1 gene.

Fetzer S, Tworek HA, Piver MS, Dicioccio RA.

Cancer Genet Cytogenet. 1998 Aug;105(1):90-2. No abstract available.

PMID:
9689938

Supplemental Content

Loading ...
Support Center